Janux Therapeutics Inc (JANX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $695.65M
Last updated: Nov 17, 2026 at 11:06 AM ET
Janux Therapeutics Inc (JANX) Earnings: Report Dates and Results
Janux Therapeutics (JANX) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Janux Therapeutics reported EPS of -$0.34, above the -$0.45 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
JANX has an expected report date of Feb 24, 2027.
Earnings History
Of the 22 quarters below that had an estimate, JANX beat 16 and missed 6. Revenue for the quarter ended Sep 30, 2026 was $9.29M, down 7.1% from $10.00M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.34 | -$0.45 | -$0.67 - -$0.04 | +24.44% | Beat | N/A | 14 | 4 up, 7 down | Nov 5, 2026 | $9.29M |
| Jun 30, 2026 | -$0.35 | -$0.26 | -$0.66 - $0.16 | -34.62% | Miss | N/A | 14 | 1 up, 1 down | Aug 6, 2026 | $10.27M |
| Mar 31, 2026 | -$0.39 | -$0.52 | -$0.66 - -$0.36 | +25.00% | Beat | N/A | 10 | 1 up, 0 down | May 7, 2026 | $3.73M |
| Dec 31, 2025 | -$0.51 | -$0.65 | -$0.94 - -$0.43 | +21.54% | Beat | N/A | 12 | 8 up, 3 down | Feb 26, 2026 | $7.88M |
| Sep 30, 2025 | -$0.39 | -$0.61 | -$1.02 - -$0.43 | +36.07% | Beat | N/A | 11 | 1 up, 6 down | Nov 6, 2025 | $10.00M |
| Jun 30, 2025 | -$0.55 | -$0.48 | -$0.69 - -$0.32 | -14.58% | Miss | N/A | 8 | 0 up, 4 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$0.38 | -$0.39 | -$0.48 - -$0.31 | +2.56% | Beat | N/A | 6 | 2 up, 3 down | May 8, 2025 | N/A |
| Dec 31, 2024 | -$0.36 | -$0.43 | -$0.67 - -$0.35 | +15.59% | Beat | N/A | 9 | 0 up, 1 down | Feb 27, 2025 | N/A |
| Sep 30, 2024 | -$0.51 | -$0.36 | -$0.44 - -$0.14 | -41.67% | Miss | N/A | 11 | 0 up, 0 down | Nov 6, 2024 | $439000 |
| Jun 30, 2024 | -$0.11 | -$0.29 | -$0.40 - -$0.19 | +62.07% | Beat | N/A | 8 | 0 up, 0 down | Aug 7, 2024 | $8.90M |
| Mar 31, 2024 | -$0.30 | -$0.33 | -$0.39 - -$0.27 | +9.09% | Beat | N/A | 8 | 0 up, 0 down | May 7, 2024 | $1.25M |
| Dec 31, 2023 | -$0.25 | -$0.39 | -$0.48 - -$0.30 | +35.90% | Beat | N/A | 5 | 0 up, 0 down | Mar 8, 2024 | $2.46M |
| Sep 30, 2023 | -$0.25 | -$0.43 | -$0.50 - -$0.38 | +41.86% | Beat | N/A | 4 | 0 up, 0 down | Nov 7, 2023 | $2.52M |
| Jun 30, 2023 | -$0.42 | -$0.51 | -$0.61 - -$0.43 | +17.65% | Beat | N/A | 4 | 0 up, 0 down | Aug 8, 2023 | $1.06M |
| Mar 31, 2023 | -$0.42 | -$0.46 | -$0.51 - -$0.44 | +8.70% | Beat | N/A | 4 | 0 up, 0 down | May 9, 2023 | $2.05M |
| Dec 31, 2022 | -$0.39 | -$0.49 | -$0.58 - -$0.41 | +20.41% | Beat | N/A | 4 | 0 up, 0 down | Mar 10, 2023 | $2.85M |
| Sep 30, 2022 | -$0.40 | -$0.53 | -$0.53 - -$0.45 | +24.53% | Beat | N/A | 3 | 0 up, 0 down | Nov 10, 2022 | $1.81M |
| Jun 30, 2022 | -$0.41 | -$0.39 | -$0.39 - -$0.35 | -5.13% | Miss | N/A | 3 | 0 up, 0 down | Aug 9, 2022 | $2.37M |
| Mar 31, 2022 | -$0.32 | -$0.37 | -$0.37 - -$0.36 | +13.51% | Beat | N/A | 3 | 0 up, 0 down | May 10, 2022 | $1.59M |
| Dec 31, 2021 | -$0.33 | -$0.31 | -$0.33 - -$0.29 | -6.45% | Miss | N/A | 3 | N/A | Mar 18, 2022 | $1.62M |
| Sep 30, 2021 | -$0.26 | -$0.17 | -$0.19 - -$0.17 | -52.94% | Miss | N/A | 3 | N/A | Nov 9, 2021 | $1.16M |
| Jun 30, 2021 | -$0.15 | -$0.16 | -$0.19 - -$0.07 | +6.25% | Beat | N/A | 2 | N/A | Aug 10, 2021 | $482000 |
| Mar 31, 2021 | -$2.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 11, 2021 | $380000 |
| Dec 31, 2020 | -$2.63 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2021 | N/A |
| Dec 31, 2019 | -$2.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.83, after -$1.28 the year before. It was -$2.20 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.83 | N/A |
| Dec 31, 2024 | -$1.28 | N/A |
| Dec 31, 2023 | -$1.34 | N/A |
| Dec 31, 2022 | -$1.52 | N/A |
| Dec 31, 2021 | -$2.76 | N/A |
| Dec 31, 2020 | -$2.63 | N/A |
| Dec 31, 2019 | -$2.20 | N/A |
Frequently Asked Questions About JANX
When is Janux Therapeutics's next earnings date?
Janux Therapeutics's next earnings report is expected for Feb 24, 2027.
Did JANX beat earnings estimates last quarter?
Yes. Janux Therapeutics reported EPS of -$0.34 for the quarter ended Sep 30, 2026, above the -$0.45 estimate, a 24.44% surprise.
What EPS do analysts expect from JANX next quarter?
The consensus EPS estimate for Janux Therapeutics for the quarter ending Dec 31, 2026 is -$0.54 from 20 analysts, with estimates from -$0.79 to $0.14.
How often does JANX beat earnings estimates?
Janux Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +9.50%.
JANX pages: Overview, Earnings, Forecast, Financials, Competitors